Employers & Consultants
3 ways the modern prescription experience is starting to look more like modern commerce
New direct-to-patient prescription models are emerging as consumers demand the same convenience, transparency, and digital control they experience…
Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access
Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…
As Seen In: Authority Magazine
Chief Executive Officer Chris Blackley on the healthcare leadership operating system
“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…
As Seen In: SHRM
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.
As Seen In: EBN
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Direct access isn’t a program – it’s market design
Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.
As Seen In: Reuters
Data shows US advertising spend increasing for pharma manufacturers
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
As Seen In: HIT Consultant
Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence
Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…
Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale
Redmond, WA – Friday, Jan. 9, 2026 — Prescryptive and Ilant Health today announced a collaboration to help…
Redefining drug access: How the Direct Marketplace helps transform sustainable drug pricing, patient affordability, and innovation
For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit…
As Seen In: EBN
A broker’s guide to breaking the rebate cycle
Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…
As Seen In: Drug Topics
Navigating GLP-1 access & complexity: 4 key insights
Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…